HK1103638A1 - Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists[73] solvay pharmaceuticals gmbh postfach 220 ; d-30002 hannover ; hans-boeckler-allee 20 d-30173 hannover ; germany - Google Patents

Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists[73] solvay pharmaceuticals gmbh postfach 220 ; d-30002 hannover ; hans-boeckler-allee 20 d-30173 hannover ; germany

Info

Publication number
HK1103638A1
HK1103638A1 HK07108160.0A HK07108160A HK1103638A1 HK 1103638 A1 HK1103638 A1 HK 1103638A1 HK 07108160 A HK07108160 A HK 07108160A HK 1103638 A1 HK1103638 A1 HK 1103638A1
Authority
HK
Hong Kong
Prior art keywords
hannover
inhibitors
boeckler
allee
nep
Prior art date
Application number
HK07108160.0A
Other languages
English (en)
Inventor
D Ziegler
K Witte
M Straub
Y Fischer
D Thormaehlen
D Hoeltje
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HK1103638A1 publication Critical patent/HK1103638A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK07108160.0A 2004-06-23 2007-07-27 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists[73] solvay pharmaceuticals gmbh postfach 220 ; d-30002 hannover ; hans-boeckler-allee 20 d-30173 hannover ; germany HK1103638A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58172304P 2004-06-23 2004-06-23
EP04102906 2004-06-23
PCT/EP2005/052915 WO2006000564A1 (en) 2004-06-23 2005-06-22 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists

Publications (1)

Publication Number Publication Date
HK1103638A1 true HK1103638A1 (en) 2007-12-28

Family

ID=34979877

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07108160.0A HK1103638A1 (en) 2004-06-23 2007-07-27 Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists[73] solvay pharmaceuticals gmbh postfach 220 ; d-30002 hannover ; hans-boeckler-allee 20 d-30173 hannover ; germany

Country Status (10)

Country Link
EP (1) EP1776095A1 (xx)
JP (1) JP2008503546A (xx)
CN (1) CN1972679B (xx)
AU (1) AU2005256634B2 (xx)
BR (1) BRPI0512379A (xx)
CA (1) CA2579716A1 (xx)
HK (1) HK1103638A1 (xx)
MX (1) MXPA06014448A (xx)
RU (1) RU2384346C2 (xx)
WO (1) WO2006000564A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
WO2007106708A2 (en) * 2006-03-10 2007-09-20 Novartis Ag Combinations of the angiotensin ii antagonist valsartan and the nep inhibitor daglutril
SI1891952T1 (sl) 2006-05-04 2012-02-29 Lek Pharmaceuticals, D.D. Farmacevtski sestavek, ki vsebuje olmesartan medoksomil
RS53012B (en) 2009-01-30 2014-04-30 Takeda Pharmaceutical Company Limited CONDENSED RING UNIT AND ITS USE
WO2017072636A1 (en) * 2015-10-29 2017-05-04 Cadila Healthcare Limited Pharmaceutical synergistic combination
CN105669581B (zh) * 2015-11-09 2017-03-22 成都苑东生物制药股份有限公司 一种血管紧张受体拮抗剂和中性内肽酶抑制剂复合物
AU2018280236B2 (en) 2017-06-07 2024-06-06 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
US11511103B2 (en) 2017-11-13 2022-11-29 Shifamed Holdings, Llc Intravascular fluid movement devices, systems, and methods of use
CN112004563A (zh) 2018-02-01 2020-11-27 施菲姆德控股有限责任公司 血管内血泵以及使用和制造方法
US11964145B2 (en) 2019-07-12 2024-04-23 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US11724089B2 (en) 2019-09-25 2023-08-15 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CN1101393C (zh) * 1996-10-29 2003-02-12 麦克公司 芦沙坦的结晶方法
ZA991922B (en) * 1998-03-11 1999-09-13 Smithkline Beecham Corp Novel compositions of eprosartan.
DK1216038T3 (da) * 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
PL367093A1 (en) * 2001-05-18 2005-02-21 Solvay Pharmaceuticals Gmbh Use of compounds with combined nep/mp-inhibitory activity in the preparation of medicaments
JP4399254B2 (ja) * 2001-06-20 2010-01-13 キッセイ薬品工業株式会社 含窒素複素環誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体
ATE370732T1 (de) * 2002-01-17 2007-09-15 Novartis Pharma Gmbh Pharmazeutische zusammensetzung enthaltend valsartan und nep-inhibitoren
AU2003268219B2 (en) * 2002-08-28 2009-09-24 Barnes-Jewish Hospital Conjoint administration of morphogens and ACE inhibitors in treatment of chronic renal failure
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid

Also Published As

Publication number Publication date
RU2007102227A (ru) 2008-07-27
CN1972679B (zh) 2010-07-28
AU2005256634A1 (en) 2006-01-05
WO2006000564A1 (en) 2006-01-05
MXPA06014448A (es) 2007-03-01
EP1776095A1 (en) 2007-04-25
CN1972679A (zh) 2007-05-30
RU2384346C2 (ru) 2010-03-20
AU2005256634B2 (en) 2010-12-09
JP2008503546A (ja) 2008-02-07
CA2579716A1 (en) 2006-01-05
BRPI0512379A (pt) 2008-03-11

Similar Documents

Publication Publication Date Title
HK1103638A1 (en) Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and at1-receptor antagonists[73] solvay pharmaceuticals gmbh postfach 220 ; d-30002 hannover ; hans-boeckler-allee 20 d-30173 hannover ; germany
IL179835A0 (en) Pharmaceutical compositions containing amphotericin b and delivery systems containing the same
ZA200702216B (en) Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists
PL2985026T3 (pl) Farmaceutyczne systemy dostarczania leków hydrofobowych i zawierające je kompozycje
EP1753380A4 (en) TRANSPARENT FORMULATIONS FOR THE DERIVATIVE DISPOSAL OF MEDICAMENTS AND METHODS OF ADMINISTRATION
IL188732A0 (en) Pharmaceutical compositions containing ibuprofen and famotidine
IL175252A0 (en) Benzimidazole derivatives and pharmaceutical compositions containing the same
IL197923A (en) Synthetic peptides, pharmaceutical preparations containing them and their uses
IL197924A (en) Synthetic peptides, pharmaceutical preparations containing them and their uses
AU2003222137A1 (en) Microgel particles for the delivery of bioactive materials
IL163366A (en) Glucocorticoid mimetics, pharmaceutical compositions thereof and uses thereof for the preparation of pharmaceutical compositions
IL196601A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
AU2003234231A1 (en) New polyarylates for drug delivery and tissue engineering
IL184758A0 (en) New pharmaceutical compositions useful in the transmucosal administration of drugs
IL164031A (en) Compositiion having gelling properaties for the prolonged delivery of bioactive substances
HK1076742A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
EP2220081A4 (en) GLUCCOAINEACTIVATORS AND THESE PHARMACEUTICAL COMPOSITIONS CONTAINING ACTIVE SUBSTANCES
EP1654380A4 (en) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING HEPARANASE ACTIVATION AND USES THEREOF
AU2003220786A1 (en) Orodispersible pharmaceutical composition comprising agomelatine
IL177073A0 (en) Hydroxy-6-heteroarylphenanthridine derivatives and pharmaceutical compositions containing the same
IL175499A (en) Pneumococcal Niraminadase non-toxic and pharmaceutical preparations containing it
IL179253A0 (en) Pyrimidine derivatives and pharmaceutical compositions containing the same
HK1076741A1 (en) Orodispersible pharmaceutical composition comprising ivabradine
HK1076743A1 (en) Orodispersible pharmaceutical composition comprising perindopril
EP1717246B8 (en) Tnf antagonists and tnf inhibitors comprising the same as the active ingredient